000287299 001__ 287299
000287299 005__ 20250415112709.0
000287299 0247_ $$2doi$$a10.1007/s00432-023-05555-8
000287299 0247_ $$2pmid$$apmid:38270814
000287299 0247_ $$2ISSN$$a0301-1585
000287299 0247_ $$2ISSN$$a0084-5353
000287299 0247_ $$2ISSN$$a0171-5216
000287299 0247_ $$2ISSN$$a1432-1335
000287299 0247_ $$2altmetric$$aaltmetric:170795982
000287299 037__ $$aDKFZ-2024-00219
000287299 041__ $$aEnglish
000287299 082__ $$a610
000287299 1001_ $$0P:(DE-He78)4efdb2a34deea12413d61f7ddc9eba99$$aMilzer, Marlena$$b0$$eFirst author
000287299 245__ $$aPatient-physician communication about cancer-related fatigue: a survey of patient-perceived barriers.
000287299 260__ $$aHeidelberg$$bSpringer$$c2024
000287299 3367_ $$2DRIVER$$aarticle
000287299 3367_ $$2DataCite$$aOutput Types/Journal article
000287299 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1706532449_23419
000287299 3367_ $$2BibTeX$$aARTICLE
000287299 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000287299 3367_ $$00$$2EndNote$$aJournal Article
000287299 500__ $$a#EA:C110#LA:C110#
000287299 520__ $$aCancer-related fatigue is a subjective, distressing, and common sequela of cancer which is often disregarded and underdiagnosed. Fatigue is assessed by self-report requiring communication between patient and physician. In this study, we investigated the patients' perspective on the patient-physician communication about fatigue.On average five months after diagnosis 1179 cancer patients, recruited in Germany, completed a survey as part of the LIFT project. The survey included questions on sociodemographic data, fatigue, depression, fatigue management, patient-physician communication, and communication barriers. Data were analyzed descriptively and using logistic regression analyses.Half of the participants reported that their physician had never asked them whether they felt exhausted. Patients undergoing chemo-, radio-, or immunotherapy were more likely to be asked about fatigue, while older age and major depression decreased the likelihood. Sixty-four percent of the patients felt impeded by communication barriers. Common barriers were not knowing who to turn to for fatigue (39%), time constraints (31%), and the fear of being perceived as weak (22%). Almost half of the participants indicated that their physicians were not appreciative and did not deal adequately with fatigue-related questions.This study revealed gaps in the patient-physician communication regarding cancer-related fatigue. Contrary to guideline recommendations a minority of physicians addressed fatigue. On the other hand, cancer patients felt reluctant to bring up this topic due to structural barriers and fears. Physicians should routinely address fatigue and adopt a communication style which encourages patients to likewise state their symptoms and raise their questions.Clinicaltrials.gov, identifier: NCT04921644. Registered in June 2021.
000287299 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000287299 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000287299 650_7 $$2Other$$aCancer-related fatigue
000287299 650_7 $$2Other$$aPatient participation
000287299 650_7 $$2Other$$aPatient–physician communication
000287299 650_7 $$2Other$$aStructural barriers
000287299 650_7 $$2Other$$aSupportive care
000287299 650_2 $$2MeSH$$aHumans
000287299 650_2 $$2MeSH$$aPhysician-Patient Relations
000287299 650_2 $$2MeSH$$aCommunication
000287299 650_2 $$2MeSH$$aPhysicians
000287299 650_2 $$2MeSH$$aNeoplasms: complications
000287299 650_2 $$2MeSH$$aNeoplasms: therapy
000287299 650_2 $$2MeSH$$aFatigue: etiology
000287299 7001_ $$aWagner, Anna S$$b1
000287299 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b2
000287299 7001_ $$00000-0002-8030-1182$$aMaatouk, Imad$$b3
000287299 7001_ $$0P:(DE-He78)a8ce1da94e91296e574e4849cfabd230$$aHermann, Silke$$b4
000287299 7001_ $$00000-0002-5815-5713$$aKiermeier, Senta$$b5
000287299 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b6$$eLast author
000287299 773__ $$0PERI:(DE-600)1459285-X$$a10.1007/s00432-023-05555-8$$gVol. 150, no. 2, p. 29$$n2$$p29$$tJournal of cancer research and clinical oncology$$v150$$x0301-1585$$y2024
000287299 8564_ $$uhttps://inrepo02.dkfz.de/record/287299/files/s00432-023-05555-8.pdf
000287299 8564_ $$uhttps://inrepo02.dkfz.de/record/287299/files/s00432-023-05555-8.pdf?subformat=pdfa$$xpdfa
000287299 8767_ $$8SN-2024-00420-b$$92024-05-28$$d2025-04-14$$eAPC$$jZahlung erfolgt
000287299 909CO $$ooai:inrepo02.dkfz.de:287299$$pVDB$$pOpenAPC$$popenCost
000287299 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4efdb2a34deea12413d61f7ddc9eba99$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000287299 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000287299 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8ce1da94e91296e574e4849cfabd230$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000287299 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000287299 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000287299 9141_ $$y2024
000287299 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000287299 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000287299 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CANCER RES CLIN : 2022$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000287299 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000287299 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000287299 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000287299 9202_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000287299 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000287299 9201_ $$0I:(DE-He78)M110-20160331$$kM110$$lM110 Epidemiologisches Krebsregister BW$$x1
000287299 9200_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000287299 980__ $$ajournal
000287299 980__ $$aVDB
000287299 980__ $$aI:(DE-He78)C110-20160331
000287299 980__ $$aI:(DE-He78)M110-20160331
000287299 980__ $$aUNRESTRICTED
000287299 980__ $$aAPC